Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation with the Children’s Oncology Group (COG), have conducted the largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure.
Amgen’s win for a Stelara interchangeable biosimilar prompts questions about ‘meaningful competition’ under IRA
The FDA approval of Amgen’s interchangeable Stelara biosimilar is raising broader questions about how potential competition could impact Medicare price negotiations for Johnson & Johnson’s
November 2, 2023